Home » Research » 587P – Clinical and cost impact of cabazitaxel vs a second (ARTA) for patients with metastatic castration-resistant prostate cancer…
Poster
Prostate
Treatment
587P – Clinical and cost impact of cabazitaxel vs a second (ARTA) for patients with metastatic castration-resistant prostate cancer…